Persica R&D

Persica Pharmaceuticals’ approach is to bring together a highly experienced and qualified team that has extensive knowledge of the drug development and clinical trial processes required to bring a new product to the market.

Persica will partner with expert Contract Research Organisations to generate the scientific & technical data that derive from the testing of antibiotics, development of formulations suitable for treating infections in the spine, demonstration of product stability and safety and efficacy evaluations.  A key attribute will be a new therapy that avoids the requirement for long-term dosing of antibiotics with the attendant risk of contributing to the spread of antibiotic resistance.

The CRO’s will be selected on the basis of having an established track record in the pharmaceutical & biotechnology sectors with an ability to generate and communicate scientific data in a timely and cost-effective manner.